Hepatocyte Growth Factor as a Prognostic Marker in Heart Failure: Promise and Challenges

Prognostic Significance of Circulating Levels of Hepatocyte Growth Factor in Patients with Chagas’ Disease and Idiopathic Dilated Cardiomyopathy

(2012) Yong Wang et al.   CARDIOLOGY

Emerging Biomarkers in Heart Failure

(2011) R. R. J. van Kimmenade et al.   CLINICAL CHEMISTRY

Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE-2 study)

(2011) Nicolas Lamblin et al.   EUROPEAN JOURNAL OF HEART FAILURE

Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure

(2011) K. Rychli et al.   HEART

Fixed-Dose Telmisartan/Hydrochlorothiazide in Comparison With Losartan/Hydrochlorothiazide in Decreasing Serum Hepatocyte Growth Factor and Improving Endothelial Dysfunction in Hypertensive Patients

(2010) Ze-Ping Hu et al.   International Heart Journal

The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine

(2010) Toshikazu NAKAMURA et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients

(2008) Domingo A. Pascual-Figal et al.   EUROPEAN HEART JOURNAL